![John Langlands](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Langlands
Geschäftsführer bei RAKOVINA THERAPEUTICS INC.
Vermögen: 3 300 $ am 31.05.2024
Profil
John Langlands is the founder of Medasystems, Inc. which was founded in 2021.
Currently, he is the Chief Operating Officer at Rakovina Therapeutics, Inc. and also works as a Principal at Langlands & Associates Consulting, Inc. He previously worked as a Director-Clinical Research at EACOM Timber Corp.
Dr. Langlands holds a doctorate degree from the University of Strathclyde.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
28.08.2023 | 50 000 ( 0,08% ) | 3 300 $ | 31.05.2024 |
Aktive Positionen von John Langlands
Unternehmen | Position | Beginn |
---|---|---|
RAKOVINA THERAPEUTICS INC. | Geschäftsführer | - |
Langlands & Associates Consulting, Inc. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von John Langlands
Unternehmen | Position | Ende |
---|---|---|
EACOM Timber Corp.
![]() EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
Medasystems, Inc.
![]() Medasystems, Inc. Packaged SoftwareTechnology Services Medasystems, Inc. is a software development company based in Menlo Park, CA. Medasystems specializes in developing software that streamlines the handling of requests for experimental therapies from healthcare providers. The company's secure and GXP compliant application acts as a centralized environment, connecting physicians and pharmaceutical companies to facilitate patient access to investigational therapies. The platform streamlines physician inquiries to life science companies for investigational medicine, including expanded access or compassionate use, post-trial access, and investigator-initiated studies. Medasystems provides pharmaceutical manufacturers with software and tools to streamline expanded access or compassionate use requests, as well as the evaluation of IIS or IST proposals, and the management of post-trial access. Medasystems, Inc. was founded by Jeffrey Thibeault, Matthew Rosen, and John Langlands. Fiona Smythe has been the CEO of the company since 2021. | Gründer | - |
Ausbildung von John Langlands
University of Strathclyde | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RAKOVINA THERAPEUTICS INC. | Finance |
Private Unternehmen | 3 |
---|---|
EACOM Timber Corp.
![]() EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Non-Energy Minerals |
Langlands & Associates Consulting, Inc. | |
Medasystems, Inc.
![]() Medasystems, Inc. Packaged SoftwareTechnology Services Medasystems, Inc. is a software development company based in Menlo Park, CA. Medasystems specializes in developing software that streamlines the handling of requests for experimental therapies from healthcare providers. The company's secure and GXP compliant application acts as a centralized environment, connecting physicians and pharmaceutical companies to facilitate patient access to investigational therapies. The platform streamlines physician inquiries to life science companies for investigational medicine, including expanded access or compassionate use, post-trial access, and investigator-initiated studies. Medasystems provides pharmaceutical manufacturers with software and tools to streamline expanded access or compassionate use requests, as well as the evaluation of IIS or IST proposals, and the management of post-trial access. Medasystems, Inc. was founded by Jeffrey Thibeault, Matthew Rosen, and John Langlands. Fiona Smythe has been the CEO of the company since 2021. | Technology Services |